Geode Capital Management’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
BPC
SCM
RA
AWA
KCM
EIM
Geode Capital Management's SOPH Position: Q1 2026 in Review
Geode Capital Management reduced its SOPHiA GENETICS (SOPH) stake by 0.49% in Q1 2026, selling an estimated $2.19K and leaving 92,146 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #3617.
Geode Capital Management first reported a position in SOPH in Q4 2021 and has held it in 18 quarters since. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.
- Geode Capital Management held 92,146 shares of SOPHiA GENETICS worth $456K as of Q1 2026.
- Geode Capital Management sold 450 SOPHiA GENETICS shares in Q1 2026, an estimated $2.19K.
- SOPHiA GENETICS made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3617 holding.
- Geode Capital Management first reported a position in SOPHiA GENETICS in Q4 2021 and has held it in 18 quarters since.
- 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.